nodes	percent_of_prediction	percent_of_DWPC	metapath
Levothyroxine—ABCB1—colon cancer	0.285	1	CbGaD
Levothyroxine—SLCO4C1—Methotrexate—colon cancer	0.138	0.238	CbGbCtD
Levothyroxine—SLCO1C1—Methotrexate—colon cancer	0.0972	0.167	CbGbCtD
Levothyroxine—SLCO1B1—Irinotecan—colon cancer	0.0597	0.103	CbGbCtD
Levothyroxine—SLCO1B3—Methotrexate—colon cancer	0.0543	0.0935	CbGbCtD
Levothyroxine—SLCO1A2—Methotrexate—colon cancer	0.0335	0.0577	CbGbCtD
Levothyroxine—ALB—Irinotecan—colon cancer	0.0327	0.0563	CbGbCtD
Levothyroxine—SLCO1B1—Methotrexate—colon cancer	0.0316	0.0544	CbGbCtD
Levothyroxine—ALB—Fluorouracil—colon cancer	0.0314	0.0541	CbGbCtD
Levothyroxine—CYP2C8—Fluorouracil—colon cancer	0.0243	0.0418	CbGbCtD
Levothyroxine—ALB—Methotrexate—colon cancer	0.0173	0.0298	CbGbCtD
Levothyroxine—ABCB1—Irinotecan—colon cancer	0.0171	0.0295	CbGbCtD
Levothyroxine—ABCB1—Vincristine—colon cancer	0.015	0.0258	CbGbCtD
Levothyroxine—CYP3A4—Irinotecan—colon cancer	0.0102	0.0177	CbGbCtD
Levothyroxine—ABCB1—Methotrexate—colon cancer	0.00905	0.0156	CbGbCtD
Levothyroxine—CYP3A4—Vincristine—colon cancer	0.00896	0.0154	CbGbCtD
Levothyroxine—Temperature intolerance—Capecitabine—colon cancer	0.00376	0.07	CcSEcCtD
Levothyroxine—SERPINA7—bone marrow—colon cancer	0.00231	0.0374	CbGeAlD
Levothyroxine—SLCO4C1—renal system—colon cancer	0.00197	0.0319	CbGeAlD
Levothyroxine—THRB—renal system—colon cancer	0.00189	0.0306	CbGeAlD
Levothyroxine—THRA—renal system—colon cancer	0.00189	0.0306	CbGeAlD
Levothyroxine—SERPINA7—liver—colon cancer	0.00187	0.0302	CbGeAlD
Levothyroxine—ALB—gall bladder—colon cancer	0.00186	0.0302	CbGeAlD
Levothyroxine—TTR—embryo—colon cancer	0.00185	0.03	CbGeAlD
Levothyroxine—Infertility—Methotrexate—colon cancer	0.00176	0.0328	CcSEcCtD
Levothyroxine—SLCO1C1—renal system—colon cancer	0.00157	0.0254	CbGeAlD
Levothyroxine—SLC7A5—epithelium—colon cancer	0.00155	0.0251	CbGeAlD
Levothyroxine—SLC7A5—smooth muscle tissue—colon cancer	0.0015	0.0242	CbGeAlD
Levothyroxine—SLCO4C1—bone marrow—colon cancer	0.00149	0.0241	CbGeAlD
Levothyroxine—SLCO4C1—vagina—colon cancer	0.00143	0.0231	CbGeAlD
Levothyroxine—Abdominal cramps—Vincristine—colon cancer	0.0014	0.0261	CcSEcCtD
Levothyroxine—TTR—renal system—colon cancer	0.0014	0.0227	CbGeAlD
Levothyroxine—SLCO1B3—vagina—colon cancer	0.00138	0.0224	CbGeAlD
Levothyroxine—Abdominal cramps—Irinotecan—colon cancer	0.00137	0.0254	CcSEcCtD
Levothyroxine—THRB—vagina—colon cancer	0.00137	0.0221	CbGeAlD
Levothyroxine—SLCO4A1—renal system—colon cancer	0.00126	0.0204	CbGeAlD
Levothyroxine—SLC16A2—vagina—colon cancer	0.00124	0.0201	CbGeAlD
Levothyroxine—SLCO4C1—liver—colon cancer	0.0012	0.0195	CbGeAlD
Levothyroxine—SLC7A5—lymphoid tissue—colon cancer	0.0012	0.0194	CbGeAlD
Levothyroxine—SLC7A5—digestive system—colon cancer	0.00118	0.0191	CbGeAlD
Levothyroxine—SLCO1B3—liver—colon cancer	0.00117	0.0189	CbGeAlD
Levothyroxine—TTR—lymphoid tissue—colon cancer	0.00116	0.0189	CbGeAlD
Levothyroxine—THRB—liver—colon cancer	0.00115	0.0187	CbGeAlD
Levothyroxine—THRA—liver—colon cancer	0.00115	0.0187	CbGeAlD
Levothyroxine—TTR—digestive system—colon cancer	0.00115	0.0186	CbGeAlD
Levothyroxine—SLCO1B1—renal system—colon cancer	0.00111	0.0179	CbGeAlD
Levothyroxine—SLC7A5—bone marrow—colon cancer	0.00109	0.0176	CbGeAlD
Levothyroxine—TTR—bone marrow—colon cancer	0.00106	0.0172	CbGeAlD
Levothyroxine—SLC16A2—liver—colon cancer	0.00104	0.0169	CbGeAlD
Levothyroxine—SLC7A5—vagina—colon cancer	0.00104	0.0169	CbGeAlD
Levothyroxine—SLCO4A1—digestive system—colon cancer	0.00103	0.0167	CbGeAlD
Levothyroxine—SLCO4A1—vagina—colon cancer	0.00091	0.0147	CbGeAlD
Levothyroxine—SLCO1B1—digestive system—colon cancer	0.000907	0.0147	CbGeAlD
Levothyroxine—SLCO1A2—renal system—colon cancer	0.0009	0.0146	CbGeAlD
Levothyroxine—THRB—lymph node—colon cancer	0.000884	0.0143	CbGeAlD
Levothyroxine—THRA—lymph node—colon cancer	0.000884	0.0143	CbGeAlD
Levothyroxine—SLC7A5—liver—colon cancer	0.000879	0.0142	CbGeAlD
Levothyroxine—Coma—Vincristine—colon cancer	0.000866	0.0161	CcSEcCtD
Levothyroxine—TTR—liver—colon cancer	0.000857	0.0139	CbGeAlD
Levothyroxine—Coma—Fluorouracil—colon cancer	0.000808	0.015	CcSEcCtD
Levothyroxine—SLC16A2—lymph node—colon cancer	0.000801	0.013	CbGeAlD
Levothyroxine—SLCO4A1—liver—colon cancer	0.000768	0.0124	CbGeAlD
Levothyroxine—SLCO1A2—digestive system—colon cancer	0.000738	0.012	CbGeAlD
Levothyroxine—SLCO1C1—lymph node—colon cancer	0.000735	0.0119	CbGeAlD
Levothyroxine—Disorientation—Fluorouracil—colon cancer	0.000718	0.0133	CcSEcCtD
Levothyroxine—Liotrix—ABCB1—colon cancer	0.000708	0.578	CrCbGaD
Levothyroxine—SLCO1B1—liver—colon cancer	0.000676	0.0109	CbGeAlD
Levothyroxine—SLC7A5—lymph node—colon cancer	0.000674	0.0109	CbGeAlD
Levothyroxine—ABCB1—blood vessel—colon cancer	0.000668	0.0108	CbGeAlD
Levothyroxine—Cardiac failure—Fluorouracil—colon cancer	0.000658	0.0122	CcSEcCtD
Levothyroxine—Cardiac arrest—Vincristine—colon cancer	0.000654	0.0122	CcSEcCtD
Levothyroxine—Dehydration—Vincristine—colon cancer	0.00064	0.0119	CcSEcCtD
Levothyroxine—Cardiac arrest—Irinotecan—colon cancer	0.000637	0.0119	CcSEcCtD
Levothyroxine—CYP2C8—renal system—colon cancer	0.000629	0.0102	CbGeAlD
Levothyroxine—Dehydration—Irinotecan—colon cancer	0.000623	0.0116	CcSEcCtD
Levothyroxine—Irritability—Fluorouracil—colon cancer	0.000613	0.0114	CcSEcCtD
Levothyroxine—Cardiac arrest—Fluorouracil—colon cancer	0.00061	0.0114	CcSEcCtD
Levothyroxine—Muscular weakness—Vincristine—colon cancer	0.000607	0.0113	CcSEcCtD
Levothyroxine—SLCO4A1—lymph node—colon cancer	0.000589	0.00954	CbGeAlD
Levothyroxine—Muscular weakness—Fluorouracil—colon cancer	0.000566	0.0105	CcSEcCtD
Levothyroxine—Angina pectoris—Irinotecan—colon cancer	0.000564	0.0105	CcSEcCtD
Levothyroxine—Sweating increased—Irinotecan—colon cancer	0.000564	0.0105	CcSEcCtD
Levothyroxine—Dysphagia—Fluorouracil—colon cancer	0.000555	0.0103	CcSEcCtD
Levothyroxine—SLCO1A2—liver—colon cancer	0.00055	0.00891	CbGeAlD
Levothyroxine—ALB—liver—colon cancer	0.000547	0.00886	CbGeAlD
Levothyroxine—Angina pectoris—Fluorouracil—colon cancer	0.00054	0.0101	CcSEcCtD
Levothyroxine—Weight decreased—Vincristine—colon cancer	0.000538	0.01	CcSEcCtD
Levothyroxine—Weight decreased—Irinotecan—colon cancer	0.000524	0.00975	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Vincristine—colon cancer	0.000523	0.00972	CcSEcCtD
Levothyroxine—Myocardial infarction—Vincristine—colon cancer	0.00052	0.00967	CcSEcCtD
Levothyroxine—Liothyronine—ABCB1—colon cancer	0.000517	0.422	CrCbGaD
Levothyroxine—Acute coronary syndrome—Irinotecan—colon cancer	0.000509	0.00947	CcSEcCtD
Levothyroxine—Sweating—Vincristine—colon cancer	0.000508	0.00946	CcSEcCtD
Levothyroxine—Myocardial infarction—Irinotecan—colon cancer	0.000506	0.00942	CcSEcCtD
Levothyroxine—Sweating—Irinotecan—colon cancer	0.000495	0.00921	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Fluorouracil—colon cancer	0.000488	0.00907	CcSEcCtD
Levothyroxine—Myocardial infarction—Fluorouracil—colon cancer	0.000485	0.00902	CcSEcCtD
Levothyroxine—Increased appetite—Capecitabine—colon cancer	0.000477	0.00888	CcSEcCtD
Levothyroxine—Cardiac failure—Capecitabine—colon cancer	0.00046	0.00855	CcSEcCtD
Levothyroxine—CYP2C8—vagina—colon cancer	0.000455	0.00738	CbGeAlD
Levothyroxine—Flushing—Irinotecan—colon cancer	0.00043	0.008	CcSEcCtD
Levothyroxine—Irritability—Capecitabine—colon cancer	0.000428	0.00796	CcSEcCtD
Levothyroxine—Cardiac arrest—Capecitabine—colon cancer	0.000427	0.00793	CcSEcCtD
Levothyroxine—CYP3A4—renal system—colon cancer	0.000426	0.0069	CbGeAlD
Levothyroxine—Mood swings—Capecitabine—colon cancer	0.000425	0.0079	CcSEcCtD
Levothyroxine—Alopecia—Vincristine—colon cancer	0.000421	0.00783	CcSEcCtD
Levothyroxine—Coma—Methotrexate—colon cancer	0.00042	0.00782	CcSEcCtD
Levothyroxine—ALB—lymph node—colon cancer	0.000419	0.00679	CbGeAlD
Levothyroxine—Dehydration—Capecitabine—colon cancer	0.000417	0.00776	CcSEcCtD
Levothyroxine—Arrhythmia—Irinotecan—colon cancer	0.000414	0.0077	CcSEcCtD
Levothyroxine—Alopecia—Irinotecan—colon cancer	0.00041	0.00762	CcSEcCtD
Levothyroxine—ABCB1—embryo—colon cancer	0.000398	0.00645	CbGeAlD
Levothyroxine—Arrhythmia—Fluorouracil—colon cancer	0.000397	0.00738	CcSEcCtD
Levothyroxine—Muscular weakness—Capecitabine—colon cancer	0.000396	0.00736	CcSEcCtD
Levothyroxine—Alopecia—Fluorouracil—colon cancer	0.000392	0.0073	CcSEcCtD
Levothyroxine—Dysphagia—Capecitabine—colon cancer	0.000388	0.00721	CcSEcCtD
Levothyroxine—CYP2C8—liver—colon cancer	0.000384	0.00623	CbGeAlD
Levothyroxine—Agitation—Vincristine—colon cancer	0.000381	0.00708	CcSEcCtD
Levothyroxine—Angina pectoris—Capecitabine—colon cancer	0.000378	0.00702	CcSEcCtD
Levothyroxine—Sweating increased—Capecitabine—colon cancer	0.000378	0.00702	CcSEcCtD
Levothyroxine—Convulsion—Vincristine—colon cancer	0.000359	0.00668	CcSEcCtD
Levothyroxine—Weight decreased—Capecitabine—colon cancer	0.000351	0.00652	CcSEcCtD
Levothyroxine—CYP3A4—digestive system—colon cancer	0.000349	0.00566	CbGeAlD
Levothyroxine—Acute coronary syndrome—Capecitabine—colon cancer	0.000341	0.00634	CcSEcCtD
Levothyroxine—Myocardial infarction—Capecitabine—colon cancer	0.000339	0.0063	CcSEcCtD
Levothyroxine—Convulsion—Fluorouracil—colon cancer	0.000335	0.00623	CcSEcCtD
Levothyroxine—Confusional state—Irinotecan—colon cancer	0.000332	0.00618	CcSEcCtD
Levothyroxine—Hyperhidrosis—Vincristine—colon cancer	0.000327	0.00608	CcSEcCtD
Levothyroxine—ABCB1—epithelium—colon cancer	0.000325	0.00527	CbGeAlD
Levothyroxine—Shock—Irinotecan—colon cancer	0.000324	0.00603	CcSEcCtD
Levothyroxine—Irritability—Methotrexate—colon cancer	0.000319	0.00593	CcSEcCtD
Levothyroxine—Hyperhidrosis—Irinotecan—colon cancer	0.000318	0.00592	CcSEcCtD
Levothyroxine—Confusional state—Fluorouracil—colon cancer	0.000318	0.00592	CcSEcCtD
Levothyroxine—Mood swings—Methotrexate—colon cancer	0.000316	0.00588	CcSEcCtD
Levothyroxine—THRA—Endochondral Ossification—FGFR3—colon cancer	0.000313	0.0181	CbGpPWpGaD
Levothyroxine—Musculoskeletal discomfort—Vincristine—colon cancer	0.000308	0.00573	CcSEcCtD
Levothyroxine—Tachycardia—Fluorouracil—colon cancer	0.000308	0.00573	CcSEcCtD
Levothyroxine—Insomnia—Vincristine—colon cancer	0.000306	0.00569	CcSEcCtD
Levothyroxine—ABCB1—renal system—colon cancer	0.000301	0.00488	CbGeAlD
Levothyroxine—Insomnia—Irinotecan—colon cancer	0.000298	0.00554	CcSEcCtD
Levothyroxine—Dyspnoea—Irinotecan—colon cancer	0.000294	0.00546	CcSEcCtD
Levothyroxine—Fatigue—Vincristine—colon cancer	0.000292	0.00542	CcSEcCtD
Levothyroxine—Flushing—Capecitabine—colon cancer	0.000288	0.00536	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000287	0.00535	CcSEcCtD
Levothyroxine—SLCO1B1—Irinotecan Pathway—APC—colon cancer	0.000287	0.0167	CbGpPWpGaD
Levothyroxine—Insomnia—Fluorouracil—colon cancer	0.000285	0.00531	CcSEcCtD
Levothyroxine—Fatigue—Irinotecan—colon cancer	0.000284	0.00528	CcSEcCtD
Levothyroxine—Dyspnoea—Fluorouracil—colon cancer	0.000281	0.00523	CcSEcCtD
Levothyroxine—Arrhythmia—Capecitabine—colon cancer	0.000277	0.00516	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Vincristine—colon cancer	0.000277	0.00514	CcSEcCtD
Levothyroxine—Alopecia—Capecitabine—colon cancer	0.000274	0.0051	CcSEcCtD
Levothyroxine—Feeling abnormal—Irinotecan—colon cancer	0.000271	0.00505	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Irinotecan—colon cancer	0.000269	0.00501	CcSEcCtD
Levothyroxine—Body temperature increased—Vincristine—colon cancer	0.000267	0.00497	CcSEcCtD
Levothyroxine—Abdominal pain—Vincristine—colon cancer	0.000267	0.00497	CcSEcCtD
Levothyroxine—Body temperature increased—Irinotecan—colon cancer	0.00026	0.00484	CcSEcCtD
Levothyroxine—Abdominal pain—Irinotecan—colon cancer	0.00026	0.00484	CcSEcCtD
Levothyroxine—CYP3A4—liver—colon cancer	0.00026	0.00422	CbGeAlD
Levothyroxine—Feeling abnormal—Fluorouracil—colon cancer	0.00026	0.00484	CcSEcCtD
Levothyroxine—Tremor—Capecitabine—colon cancer	0.000253	0.00471	CcSEcCtD
Levothyroxine—Urticaria—Fluorouracil—colon cancer	0.000251	0.00466	CcSEcCtD
Levothyroxine—ABCB1—lymphoid tissue—colon cancer	0.00025	0.00406	CbGeAlD
Levothyroxine—CYP2C8—Metapathway biotransformation—CHST4—colon cancer	0.00025	0.0145	CbGpPWpGaD
Levothyroxine—Body temperature increased—Fluorouracil—colon cancer	0.000249	0.00464	CcSEcCtD
Levothyroxine—ABCB1—digestive system—colon cancer	0.000247	0.00401	CbGeAlD
Levothyroxine—Sweating—Methotrexate—colon cancer	0.000247	0.00459	CcSEcCtD
Levothyroxine—Asthenia—Vincristine—colon cancer	0.000243	0.00451	CcSEcCtD
Levothyroxine—Palpitations—Capecitabine—colon cancer	0.000239	0.00444	CcSEcCtD
Levothyroxine—Asthenia—Irinotecan—colon cancer	0.000236	0.0044	CcSEcCtD
Levothyroxine—Diarrhoea—Vincristine—colon cancer	0.000231	0.0043	CcSEcCtD
Levothyroxine—Arthralgia—Capecitabine—colon cancer	0.00023	0.00428	CcSEcCtD
Levothyroxine—Anxiety—Capecitabine—colon cancer	0.000229	0.00426	CcSEcCtD
Levothyroxine—ABCB1—bone marrow—colon cancer	0.000228	0.00369	CbGeAlD
Levothyroxine—Diarrhoea—Irinotecan—colon cancer	0.000225	0.00419	CcSEcCtD
Levothyroxine—Pruritus—Fluorouracil—colon cancer	0.000223	0.00415	CcSEcCtD
Levothyroxine—Confusional state—Capecitabine—colon cancer	0.000222	0.00413	CcSEcCtD
Levothyroxine—ABCB1—vagina—colon cancer	0.000218	0.00354	CbGeAlD
Levothyroxine—Shock—Capecitabine—colon cancer	0.000217	0.00403	CcSEcCtD
Levothyroxine—Diarrhoea—Fluorouracil—colon cancer	0.000216	0.00402	CcSEcCtD
Levothyroxine—Tachycardia—Capecitabine—colon cancer	0.000215	0.004	CcSEcCtD
Levothyroxine—Vomiting—Vincristine—colon cancer	0.000215	0.004	CcSEcCtD
Levothyroxine—Rash—Vincristine—colon cancer	0.000213	0.00397	CcSEcCtD
Levothyroxine—Hyperhidrosis—Capecitabine—colon cancer	0.000213	0.00396	CcSEcCtD
Levothyroxine—Dermatitis—Vincristine—colon cancer	0.000213	0.00396	CcSEcCtD
Levothyroxine—Headache—Vincristine—colon cancer	0.000212	0.00394	CcSEcCtD
Levothyroxine—Vomiting—Irinotecan—colon cancer	0.000209	0.0039	CcSEcCtD
Levothyroxine—Rash—Irinotecan—colon cancer	0.000208	0.00386	CcSEcCtD
Levothyroxine—Dermatitis—Irinotecan—colon cancer	0.000207	0.00386	CcSEcCtD
Levothyroxine—Headache—Irinotecan—colon cancer	0.000206	0.00384	CcSEcCtD
Levothyroxine—Alopecia—Methotrexate—colon cancer	0.000204	0.0038	CcSEcCtD
Levothyroxine—Nausea—Vincristine—colon cancer	0.000201	0.00374	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000201	0.00374	CcSEcCtD
Levothyroxine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—EP300—colon cancer	0.000201	0.0116	CbGpPWpGaD
Levothyroxine—Vomiting—Fluorouracil—colon cancer	0.000201	0.00373	CcSEcCtD
Levothyroxine—Insomnia—Capecitabine—colon cancer	0.000199	0.00371	CcSEcCtD
Levothyroxine—Rash—Fluorouracil—colon cancer	0.000199	0.0037	CcSEcCtD
Levothyroxine—Dermatitis—Fluorouracil—colon cancer	0.000199	0.0037	CcSEcCtD
Levothyroxine—Headache—Fluorouracil—colon cancer	0.000198	0.00368	CcSEcCtD
Levothyroxine—Dyspnoea—Capecitabine—colon cancer	0.000197	0.00366	CcSEcCtD
Levothyroxine—Nausea—Irinotecan—colon cancer	0.000196	0.00364	CcSEcCtD
Levothyroxine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—SRC—colon cancer	0.000195	0.0113	CbGpPWpGaD
Levothyroxine—CYP3A4—Codeine and Morphine Metabolism—ABCB1—colon cancer	0.000192	0.0111	CbGpPWpGaD
Levothyroxine—Fatigue—Capecitabine—colon cancer	0.00019	0.00354	CcSEcCtD
Levothyroxine—Nausea—Fluorouracil—colon cancer	0.000187	0.00349	CcSEcCtD
Levothyroxine—ABCB1—liver—colon cancer	0.000184	0.00298	CbGeAlD
Levothyroxine—Feeling abnormal—Capecitabine—colon cancer	0.000182	0.00338	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Capecitabine—colon cancer	0.00018	0.00335	CcSEcCtD
Levothyroxine—Urticaria—Capecitabine—colon cancer	0.000175	0.00326	CcSEcCtD
Levothyroxine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	0.000175	0.0101	CbGpPWpGaD
Levothyroxine—Abdominal pain—Capecitabine—colon cancer	0.000174	0.00324	CcSEcCtD
Levothyroxine—Body temperature increased—Capecitabine—colon cancer	0.000174	0.00324	CcSEcCtD
Levothyroxine—Convulsion—Methotrexate—colon cancer	0.000174	0.00324	CcSEcCtD
Levothyroxine—THRA—Endochondral Ossification—VEGFA—colon cancer	0.000172	0.00996	CbGpPWpGaD
Levothyroxine—Arthralgia—Methotrexate—colon cancer	0.000171	0.00318	CcSEcCtD
Levothyroxine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	0.000171	0.00993	CbGpPWpGaD
Levothyroxine—Confusional state—Methotrexate—colon cancer	0.000165	0.00308	CcSEcCtD
Levothyroxine—Hyperhidrosis—Methotrexate—colon cancer	0.000159	0.00295	CcSEcCtD
Levothyroxine—Asthenia—Capecitabine—colon cancer	0.000158	0.00294	CcSEcCtD
Levothyroxine—THRA—Endochondral Ossification—TGFB1—colon cancer	0.000158	0.00914	CbGpPWpGaD
Levothyroxine—TTR—Non-integrin membrane-ECM interactions—TGFB1—colon cancer	0.000157	0.00912	CbGpPWpGaD
Levothyroxine—Pruritus—Capecitabine—colon cancer	0.000156	0.0029	CcSEcCtD
Levothyroxine—Diarrhoea—Capecitabine—colon cancer	0.000151	0.00281	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Methotrexate—colon cancer	0.00015	0.00278	CcSEcCtD
Levothyroxine—Insomnia—Methotrexate—colon cancer	0.000148	0.00276	CcSEcCtD
Levothyroxine—Dyspnoea—Methotrexate—colon cancer	0.000146	0.00272	CcSEcCtD
Levothyroxine—ALB—FOXA2 and FOXA3 transcription factor networks—HNF4A—colon cancer	0.000146	0.00846	CbGpPWpGaD
Levothyroxine—Fatigue—Methotrexate—colon cancer	0.000141	0.00263	CcSEcCtD
Levothyroxine—ABCB1—lymph node—colon cancer	0.000141	0.00229	CbGeAlD
Levothyroxine—Vomiting—Capecitabine—colon cancer	0.00014	0.00261	CcSEcCtD
Levothyroxine—Rash—Capecitabine—colon cancer	0.000139	0.00259	CcSEcCtD
Levothyroxine—Dermatitis—Capecitabine—colon cancer	0.000139	0.00258	CcSEcCtD
Levothyroxine—Headache—Capecitabine—colon cancer	0.000138	0.00257	CcSEcCtD
Levothyroxine—Feeling abnormal—Methotrexate—colon cancer	0.000135	0.00252	CcSEcCtD
Levothyroxine—CYP3A4—Metapathway biotransformation—CHST4—colon cancer	0.000134	0.00779	CbGpPWpGaD
Levothyroxine—Gastrointestinal pain—Methotrexate—colon cancer	0.000134	0.0025	CcSEcCtD
Levothyroxine—THRB—Generic Transcription Pathway—HNF4A—colon cancer	0.000132	0.00767	CbGpPWpGaD
Levothyroxine—THRA—Generic Transcription Pathway—HNF4A—colon cancer	0.000132	0.00767	CbGpPWpGaD
Levothyroxine—Nausea—Capecitabine—colon cancer	0.000131	0.00244	CcSEcCtD
Levothyroxine—Urticaria—Methotrexate—colon cancer	0.00013	0.00243	CcSEcCtD
Levothyroxine—Abdominal pain—Methotrexate—colon cancer	0.00013	0.00241	CcSEcCtD
Levothyroxine—Body temperature increased—Methotrexate—colon cancer	0.00013	0.00241	CcSEcCtD
Levothyroxine—Asthenia—Methotrexate—colon cancer	0.000118	0.00219	CcSEcCtD
Levothyroxine—Pruritus—Methotrexate—colon cancer	0.000116	0.00216	CcSEcCtD
Levothyroxine—CYP2C8—Metapathway biotransformation—CHST5—colon cancer	0.000115	0.00666	CbGpPWpGaD
Levothyroxine—Diarrhoea—Methotrexate—colon cancer	0.000112	0.00209	CcSEcCtD
Levothyroxine—THRA—Endochondral Ossification—AKT1—colon cancer	0.00011	0.00635	CbGpPWpGaD
Levothyroxine—SLC7A5—Cell surface interactions at the vascular wall—SRC—colon cancer	0.000106	0.00613	CbGpPWpGaD
Levothyroxine—TTR—FOXA2 and FOXA3 transcription factor networks—AKT1—colon cancer	0.000105	0.00611	CbGpPWpGaD
Levothyroxine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	0.000105	0.0061	CbGpPWpGaD
Levothyroxine—Vomiting—Methotrexate—colon cancer	0.000104	0.00194	CcSEcCtD
Levothyroxine—Rash—Methotrexate—colon cancer	0.000103	0.00192	CcSEcCtD
Levothyroxine—Dermatitis—Methotrexate—colon cancer	0.000103	0.00192	CcSEcCtD
Levothyroxine—Headache—Methotrexate—colon cancer	0.000103	0.00191	CcSEcCtD
Levothyroxine—SLC7A5—Cell surface interactions at the vascular wall—NRAS—colon cancer	0.000102	0.0059	CbGpPWpGaD
Levothyroxine—TTR—Disease—LGR5—colon cancer	9.95e-05	0.00577	CbGpPWpGaD
Levothyroxine—TTR—Disease—CHST5—colon cancer	9.95e-05	0.00577	CbGpPWpGaD
Levothyroxine—THRB—SIDS Susceptibility Pathways—CASP3—colon cancer	9.92e-05	0.00575	CbGpPWpGaD
Levothyroxine—Nausea—Methotrexate—colon cancer	9.75e-05	0.00181	CcSEcCtD
Levothyroxine—THRB—SIDS Susceptibility Pathways—CTNNB1—colon cancer	9.57e-05	0.00555	CbGpPWpGaD
Levothyroxine—ABCB1—HIF-1-alpha transcription factor network—HNF4A—colon cancer	9.24e-05	0.00536	CbGpPWpGaD
Levothyroxine—THRB—SIDS Susceptibility Pathways—EP300—colon cancer	8.89e-05	0.00516	CbGpPWpGaD
Levothyroxine—CYP3A4—Irinotecan Pathway—APC—colon cancer	8.86e-05	0.00514	CbGpPWpGaD
Levothyroxine—SLC7A5—Cell surface interactions at the vascular wall—KRAS—colon cancer	8.76e-05	0.00508	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—CA7—colon cancer	8.51e-05	0.00494	CbGpPWpGaD
Levothyroxine—THRB—SIDS Susceptibility Pathways—VEGFA—colon cancer	8.42e-05	0.00488	CbGpPWpGaD
Levothyroxine—SLC7A5—Cell surface interactions at the vascular wall—PIK3CA—colon cancer	8.05e-05	0.00467	CbGpPWpGaD
Levothyroxine—SLC7A5—Cell surface interactions at the vascular wall—HRAS—colon cancer	7.44e-05	0.00432	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—DLC1—colon cancer	7.41e-05	0.0043	CbGpPWpGaD
Levothyroxine—TTR—Disease—AXIN2—colon cancer	7.15e-05	0.00414	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—LGR5—colon cancer	6.97e-05	0.00404	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	6.88e-05	0.00399	CbGpPWpGaD
Levothyroxine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	6.82e-05	0.00396	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—CA7—colon cancer	6.69e-05	0.00388	CbGpPWpGaD
Levothyroxine—THRB—Gene Expression—HNF4A—colon cancer	6.37e-05	0.00369	CbGpPWpGaD
Levothyroxine—THRA—Gene Expression—HNF4A—colon cancer	6.37e-05	0.00369	CbGpPWpGaD
Levothyroxine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	6.34e-05	0.00368	CbGpPWpGaD
Levothyroxine—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	6.16e-05	0.00357	CbGpPWpGaD
Levothyroxine—SLCO4C1—Transmembrane transport of small molecules—ABCB1—colon cancer	6.13e-05	0.00356	CbGpPWpGaD
Levothyroxine—SLCO4A1—Transmembrane transport of small molecules—ABCB1—colon cancer	6.13e-05	0.00356	CbGpPWpGaD
Levothyroxine—TTR—Extracellular matrix organization—CDH1—colon cancer	6.06e-05	0.00351	CbGpPWpGaD
Levothyroxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	6.04e-05	0.0035	CbGpPWpGaD
Levothyroxine—THRB—Generic Transcription Pathway—PPARG—colon cancer	5.74e-05	0.00333	CbGpPWpGaD
Levothyroxine—THRA—Generic Transcription Pathway—PPARG—colon cancer	5.74e-05	0.00333	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—CA7—colon cancer	5.72e-05	0.00332	CbGpPWpGaD
Levothyroxine—SLC7A5—Transmembrane transport of small molecules—ABCB1—colon cancer	5.61e-05	0.00325	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—ODC1—colon cancer	5.16e-05	0.00299	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—CHST5—colon cancer	5.16e-05	0.00299	CbGpPWpGaD
Levothyroxine—SLCO1C1—Transmembrane transport of small molecules—ABCB1—colon cancer	5.14e-05	0.00298	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—AXIN2—colon cancer	5e-05	0.0029	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	4.69e-05	0.00272	CbGpPWpGaD
Levothyroxine—TTR—Extracellular matrix organization—CASP3—colon cancer	4.64e-05	0.00269	CbGpPWpGaD
Levothyroxine—CYP2C8—Arachidonic acid metabolism—PTGS2—colon cancer	4.53e-05	0.00262	CbGpPWpGaD
Levothyroxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	4.2e-05	0.00244	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—CHST5—colon cancer	4.05e-05	0.00235	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—ODC1—colon cancer	4.05e-05	0.00235	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	3.95e-05	0.00229	CbGpPWpGaD
Levothyroxine—TTR—Extracellular matrix organization—TGFB1—colon cancer	3.62e-05	0.0021	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—CHST5—colon cancer	3.47e-05	0.00201	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—ODC1—colon cancer	3.47e-05	0.00201	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CA7—colon cancer	3.29e-05	0.00191	CbGpPWpGaD
Levothyroxine—THRA—Generic Transcription Pathway—MYC—colon cancer	3.27e-05	0.0019	CbGpPWpGaD
Levothyroxine—THRB—Generic Transcription Pathway—MYC—colon cancer	3.27e-05	0.0019	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CA7—colon cancer	3.27e-05	0.0019	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	3.16e-05	0.00183	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—EP300—colon cancer	2.95e-05	0.00171	CbGpPWpGaD
Levothyroxine—SLCO1B3—Transmembrane transport of small molecules—ABCB1—colon cancer	2.91e-05	0.00169	CbGpPWpGaD
Levothyroxine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	2.9e-05	0.00168	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—SRC—colon cancer	2.87e-05	0.00166	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CA7—colon cancer	2.86e-05	0.00166	CbGpPWpGaD
Levothyroxine—ALB—Selenium Micronutrient Network—PTGS2—colon cancer	2.86e-05	0.00166	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—VEGFA—colon cancer	2.79e-05	0.00162	CbGpPWpGaD
Levothyroxine—THRB—Gene Expression—PPARG—colon cancer	2.76e-05	0.0016	CbGpPWpGaD
Levothyroxine—THRA—Gene Expression—PPARG—colon cancer	2.76e-05	0.0016	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—NRAS—colon cancer	2.76e-05	0.0016	CbGpPWpGaD
Levothyroxine—ABCB1—HIF-1-alpha transcription factor network—EP300—colon cancer	2.63e-05	0.00152	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—TGFB1—colon cancer	2.56e-05	0.00149	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—CASP3—colon cancer	2.54e-05	0.00147	CbGpPWpGaD
Levothyroxine—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—colon cancer	2.5e-05	0.00145	CbGpPWpGaD
Levothyroxine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—colon cancer	2.49e-05	0.00144	CbGpPWpGaD
Levothyroxine—ALB—Platelet degranulation—VEGFA—colon cancer	2.43e-05	0.00141	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	2.42e-05	0.0014	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—KRAS—colon cancer	2.37e-05	0.00138	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	2.33e-05	0.00135	CbGpPWpGaD
Levothyroxine—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—colon cancer	2.32e-05	0.00134	CbGpPWpGaD
Levothyroxine—SLCO1A2—Transmembrane transport of small molecules—ABCB1—colon cancer	2.29e-05	0.00133	CbGpPWpGaD
Levothyroxine—ALB—Platelet degranulation—TGFB1—colon cancer	2.23e-05	0.0013	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—PIK3CA—colon cancer	2.18e-05	0.00127	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—VEGFA—colon cancer	2.15e-05	0.00125	CbGpPWpGaD
Levothyroxine—ALB—Folate Metabolism—TP53—colon cancer	2.14e-05	0.00124	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.13e-05	0.00123	CbGpPWpGaD
Levothyroxine—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—colon cancer	2.13e-05	0.00123	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—TP53—colon cancer	2.11e-05	0.00122	CbGpPWpGaD
Levothyroxine—TTR—Disease—FGFR3—colon cancer	2.06e-05	0.0012	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—HRAS—colon cancer	2.02e-05	0.00117	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ODC1—colon cancer	1.99e-05	0.00115	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CHST5—colon cancer	1.99e-05	0.00115	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—ODC1—colon cancer	1.98e-05	0.00115	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CHST5—colon cancer	1.98e-05	0.00115	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—TGFB1—colon cancer	1.98e-05	0.00115	CbGpPWpGaD
Levothyroxine—SLCO1B1—Transmembrane transport of small molecules—ABCB1—colon cancer	1.96e-05	0.00113	CbGpPWpGaD
Levothyroxine—TTR—Disease—APC—colon cancer	1.89e-05	0.0011	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—AKT1—colon cancer	1.78e-05	0.00103	CbGpPWpGaD
Levothyroxine—TTR—Disease—BRAF—colon cancer	1.78e-05	0.00103	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	1.78e-05	0.00103	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CA7—colon cancer	1.76e-05	0.00102	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ODC1—colon cancer	1.74e-05	0.00101	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CHST5—colon cancer	1.74e-05	0.00101	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.68e-05	0.000971	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.67e-05	0.00097	CbGpPWpGaD
Levothyroxine—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	1.59e-05	0.00092	CbGpPWpGaD
Levothyroxine—THRA—Gene Expression—MYC—colon cancer	1.58e-05	0.000914	CbGpPWpGaD
Levothyroxine—THRB—Gene Expression—MYC—colon cancer	1.58e-05	0.000914	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—FGFR3—colon cancer	1.45e-05	0.000838	CbGpPWpGaD
Levothyroxine—TTR—Disease—PTGS2—colon cancer	1.44e-05	0.000834	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.43e-05	0.00083	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.39e-05	0.000808	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—ABCB1—colon cancer	1.36e-05	0.00079	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	1.35e-05	0.000782	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—TYMS—colon cancer	1.34e-05	0.000776	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—APC—colon cancer	1.33e-05	0.000769	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.32e-05	0.000763	CbGpPWpGaD
Levothyroxine—TTR—Disease—CTNNB1—colon cancer	1.29e-05	0.000746	CbGpPWpGaD
Levothyroxine—TTR—Disease—CDKN1A—colon cancer	1.26e-05	0.000729	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	1.25e-05	0.000726	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—BRAF—colon cancer	1.25e-05	0.000723	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	1.22e-05	0.000707	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	1.21e-05	0.0007	CbGpPWpGaD
Levothyroxine—TTR—Disease—EP300—colon cancer	1.2e-05	0.000694	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	1.18e-05	0.000684	CbGpPWpGaD
Levothyroxine—TTR—Disease—SRC—colon cancer	1.16e-05	0.000675	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.13e-05	0.000653	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	1.12e-05	0.000651	CbGpPWpGaD
Levothyroxine—TTR—Disease—NRAS—colon cancer	1.12e-05	0.000649	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—ABCB1—colon cancer	1.12e-05	0.000648	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—SRC—colon cancer	1.11e-05	0.000643	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.09e-05	0.000635	CbGpPWpGaD
Levothyroxine—THRA—Gene Expression—AKT1—colon cancer	1.09e-05	0.000634	CbGpPWpGaD
Levothyroxine—THRB—Gene Expression—AKT1—colon cancer	1.09e-05	0.000634	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	1.09e-05	0.000633	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—VEGFA—colon cancer	1.08e-05	0.000626	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—ABCB1—colon cancer	1.07e-05	0.000621	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ODC1—colon cancer	1.07e-05	0.00062	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CHST5—colon cancer	1.07e-05	0.00062	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	1.06e-05	0.000616	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—TYMS—colon cancer	1.05e-05	0.00061	CbGpPWpGaD
Levothyroxine—TTR—Disease—MYC—colon cancer	1.04e-05	0.000605	CbGpPWpGaD
Levothyroxine—TTR—Disease—TGFB1—colon cancer	1.04e-05	0.000603	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.03e-05	0.000598	CbGpPWpGaD
Levothyroxine—TTR—Disease—EGFR—colon cancer	1.02e-05	0.000591	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—TGFB1—colon cancer	9.91e-06	0.000574	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	9.78e-06	0.000567	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	9.76e-06	0.000566	CbGpPWpGaD
Levothyroxine—TTR—Disease—KRAS—colon cancer	9.63e-06	0.000559	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	9.56e-06	0.000555	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PPARG—colon cancer	9.48e-06	0.00055	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—colon cancer	9.36e-06	0.000543	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CASP3—colon cancer	9.35e-06	0.000542	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—ABCB1—colon cancer	9.16e-06	0.000531	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CCND1—colon cancer	9.1e-06	0.000528	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	9.04e-06	0.000524	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CTNNB1—colon cancer	9.01e-06	0.000523	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—TYMS—colon cancer	8.99e-06	0.000522	CbGpPWpGaD
Levothyroxine—TTR—Disease—PIK3CA—colon cancer	8.85e-06	0.000513	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CDKN1A—colon cancer	8.81e-06	0.000511	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	8.43e-06	0.000489	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—EP300—colon cancer	8.38e-06	0.000486	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	8.3e-06	0.000481	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	8.22e-06	0.000477	CbGpPWpGaD
Levothyroxine—TTR—Disease—HRAS—colon cancer	8.19e-06	0.000475	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PPARG—colon cancer	8.17e-06	0.000474	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—SRC—colon cancer	8.15e-06	0.000472	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	8.1e-06	0.00047	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	8.03e-06	0.000466	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—VEGFA—colon cancer	7.94e-06	0.00046	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—NRAS—colon cancer	7.84e-06	0.000455	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PTGS2—colon cancer	7.46e-06	0.000433	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PPARG—colon cancer	7.45e-06	0.000432	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—MYC—colon cancer	7.3e-06	0.000423	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—TGFB1—colon cancer	7.28e-06	0.000422	CbGpPWpGaD
Levothyroxine—TTR—Disease—AKT1—colon cancer	7.23e-06	0.000419	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—EGFR—colon cancer	7.14e-06	0.000414	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	6.92e-06	0.000402	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—AKT1—colon cancer	6.89e-06	0.000399	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	6.78e-06	0.000393	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—KRAS—colon cancer	6.75e-06	0.000391	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	6.47e-06	0.000375	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	6.43e-06	0.000373	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PPARG—colon cancer	6.37e-06	0.000369	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—EP300—colon cancer	6.2e-06	0.00036	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—PIK3CA—colon cancer	6.2e-06	0.000359	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—TP53—colon cancer	6e-06	0.000348	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—EP300—colon cancer	5.87e-06	0.000341	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PTGS2—colon cancer	5.86e-06	0.00034	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—HRAS—colon cancer	5.73e-06	0.000333	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—SRC—colon cancer	5.71e-06	0.000331	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—VEGFA—colon cancer	5.56e-06	0.000323	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—NRAS—colon cancer	5.5e-06	0.000319	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.38e-06	0.000312	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.35e-06	0.00031	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ABCB1—colon cancer	5.26e-06	0.000305	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—ABCB1—colon cancer	5.23e-06	0.000303	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—TYMS—colon cancer	5.17e-06	0.0003	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—TYMS—colon cancer	5.14e-06	0.000298	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—TGFB1—colon cancer	5.11e-06	0.000296	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—AKT1—colon cancer	5.06e-06	0.000294	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PTGS2—colon cancer	5.01e-06	0.000291	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—EP300—colon cancer	4.87e-06	0.000283	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—KRAS—colon cancer	4.73e-06	0.000274	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PIK3CA—colon cancer	4.59e-06	0.000266	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—TYMS—colon cancer	4.5e-06	0.000261	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—PIK3CA—colon cancer	4.35e-06	0.000252	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—TP53—colon cancer	4.2e-06	0.000244	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—EP300—colon cancer	4.17e-06	0.000242	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—HRAS—colon cancer	4.02e-06	0.000233	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.98e-06	0.000231	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.96e-06	0.000229	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—AKT1—colon cancer	3.75e-06	0.000217	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PPARG—colon cancer	3.66e-06	0.000212	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PPARG—colon cancer	3.64e-06	0.000211	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PIK3CA—colon cancer	3.61e-06	0.000209	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—AKT1—colon cancer	3.55e-06	0.000206	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PPARG—colon cancer	3.19e-06	0.000185	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PIK3CA—colon cancer	3.08e-06	0.000179	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—AKT1—colon cancer	2.95e-06	0.000171	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PTGS2—colon cancer	2.88e-06	0.000167	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PTGS2—colon cancer	2.86e-06	0.000166	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ABCB1—colon cancer	2.82e-06	0.000164	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—TYMS—colon cancer	2.77e-06	0.000161	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—AKT1—colon cancer	2.52e-06	0.000146	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PTGS2—colon cancer	2.51e-06	0.000146	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—EP300—colon cancer	2.4e-06	0.000139	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—EP300—colon cancer	2.38e-06	0.000138	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—EP300—colon cancer	2.09e-06	0.000121	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PPARG—colon cancer	1.97e-06	0.000114	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PIK3CA—colon cancer	1.77e-06	0.000103	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PIK3CA—colon cancer	1.76e-06	0.000102	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PTGS2—colon cancer	1.55e-06	8.96e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PIK3CA—colon cancer	1.54e-06	8.95e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—AKT1—colon cancer	1.45e-06	8.39e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—AKT1—colon cancer	1.44e-06	8.35e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—EP300—colon cancer	1.29e-06	7.46e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—AKT1—colon cancer	1.26e-06	7.31e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PIK3CA—colon cancer	9.51e-07	5.52e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—AKT1—colon cancer	7.77e-07	4.51e-05	CbGpPWpGaD
